Malignant Neoplasm of Unknown Primary — Trials

Malignant Neoplasm of Unknown Primary — Trials · CancerIndex

Clinical trials

Registered studies

14,253 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 4,158
Recruiting: 2,260
Ph III recruiting: 268
Growth YoY: +13.9%
Industry share: 23%
Top sponsor: National Cancer Institute (NCI)
Termination share: 35.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,895)

clinicaltrialsPublishedShowing 701–750 of 776 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01227018	PhII Study STA-9090 as Second or Third-Line Therapy for Metastatic Pancreas Cancer	terminated	Phase 2	15	Vanderbilt-Ingram Cancer CenterOTHER	1	Jul 23, 2014	clinicaltrials
NCT01491633	Dasatinib in Advanced Squamous Cell Lung Cancer	terminated	Phase 2	5	Dana-Farber Cancer InstituteOTHER	1	Jul 15, 2014	clinicaltrials